# DEFERASIROX
> **ANDA214341** · Abbreviated New Drug Application (Generic) · Sponsor: ANNORA PHARMA · Approved 2021-05-14
## Drug
- **FDA Application Number:** ANDA214341
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEFERASIROX
- **Generic name:** DEFERASIROX
- **Active ingredients:** DEFERASIROX
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ANNORA PHARMA
- **Manufacturer:** Camber Pharmaceuticals, Inc.
- **First approval:** 2021-05-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214341)
---
*AI Analytics · CC0 1.0*